Background/Objectives: Studies on human herpesvirus 8 (HHV8) infection in patients with AIDS-associated Kaposi sarcoma (AIDS-KS), from Nigeria are lacking. We examined the seroprevalence of HHV8 infection in patients with AIDS-KS presenting to Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, and also described their clinical presentation. Methods: A total of 20 (11 males and 9 females) histologically confirmed adults with AIDS-KS were recruited consecutively in 2007. The clinical types of lesions, associated diseases, and the AIDS clinical trial group staging of AIDS-KS were noted. Anti-lytic HHV8 antibodies were determined by enzyme-linked immunosorbent assay (ELISA). Results: Kaposi sarcoma skin lesions were diverse but mostly nodules (19 cases) and papules (16). Majority (18 cases) had poor risk AIDS-KS, with 10 (50%) patients having concomitant opportunistic infections and 3 (15%) patients having generalized skin lesions. Females had a more severe disease. Seventeen patients (85%) were HHV8-seropositive. Conclusion: AIDS-KS is associated with high HHV8 infection and presents with a variety of skin manifestations that are often aggressive, advanced, and worse in females.
Introduction
Kaposi sarcoma (KS) is a multicentric neoplasm of endothelial origin characterized by vascular lesions that may affect the skin, mucous membranes, or viscera. 1 The gamma herpes virus named human herpes virus 8 (HHV8) is now established as the major etiological factor in all forms of KS including endemic, classic, transplant-related, and epidemic or AIDS-related KS (AIDS-KS). 1, 2 With the emergence of the HIV/AIDS pandemic in the last three decades, the incidence of AIDS-KS has risen above other forms of KS in many parts of the world. 3 Currently, AIDS-KS remains the commonest malignancy in patients living with HIV/AIDS and also a common cause of morbidity and mortality in HIV-infected patients worldwide. 4, 5 The prevention and management of AIDS-KS continues to pose challenges to countries in Africa since both HHV8 and HIV infections are endemic in this region. 6, 7 In Nigeria, several studies have described the clinical presentations of patients with AIDS-KS, [8] [9] [10] [11] but there exists a dearth of information on HHV8 infection in patients with AIDS-KS from Nigeria. This study was undertaken to determine the seroprevalence of HHV8 infection in patients with AIDS-KS, in Zaria, Northern Nigeria, and also to describe their pattern of clinical presentation.
Patients and Methods
A 1-year cross-sectional descriptive study beginning in June 2007 enrolled 20 consecutive cases of AIDS-KS as they presented to the HIV/AIDS clinic, the oncology unit, and the medical wards of Ahmadu Bello University Teaching hospital Zaria (ABUTH) Kaduna state, Nigeria. All cases were histologically confirmed as KS from biopsy of the skin lesions. ABUTH is a major referral hospital in Nigeria, providing services to more than 6 states in Northern Nigeria.
Ethical approval and informed consent for the study (including consent for clinical photos) were obtained from the ABUTH research ethical committee and study participants, respectively.
Clinical Evaluation of AIDS-KS
The demographic data, clinical histories, and treatment histories for each patient were noted. All patients were examined to determine the anatomical locations, the clinical types of KS lesions, and the diseases associated with AIDS-KS. Skin lesions were described as invasive when associated with ulcers, lymphaedema, or tissue infiltration. Patients were staged into either good risk or poor risk AIDS-KS, according to the tumor, immunity, and systemic symptoms (TIS) staging of the AIDS Clinical Trial Group (ACTG). 12 Briefly, those classified as poor risk KS had any of the following: (a) T ¼ invasive lesions (b) I ¼ CD4 count <200 cells/mm 3 , and (c) S ¼ presence of systemic symptoms or opportunistic infections. Good risk AIDS-KS were cases with noninvasive skin lesions, CD4 count >200 cells/mm 3 , and absence of systemic symptoms or opportunistic infections.
Laboratory Methods and Assay of HHV8 Infection
Complete blood count, stool culture (including modified Ziehl Nielsen stain for cryptosporidium), blood and urine culture, chest X-ray, and lymph node biopsy for histopathology were done as necessary. Internal organs (viscera) were however not biopsied or evaluated for KS lesions by endoscopy as a result of resource constraints. HIV-1 infection was confirmed by Western blot, while CD4 count was determined by flow cytometry (Partec, GmbH Munster Germany).
Serum samples collected from all patients were stored at À20 C until collectively analyzed for immunoglobulin G (IgG) HHV8 anti-lytic antigen antibodies (BIOTRIN, UK), according to manufacturer's brochure. 13 This test kit has a sensitivity of 90.4% and specificity of 93%. 13 HHV8 results were interpreted as positive when samples were reactive and negative when samples were nonreactive. Equivocal samples were excluded.
Gender differences in data were sought by nonparametric test using SPSS 15. P < .05 was considered significant.
Results
The demographic and clinical data of patients are shown in Table 1 . Transmission of HIV was by heterosexual contact in all patients. Of the 20 cases, there were 11 males and 9 were females. The occupations of the patients included 6 civil servants, 5 housewives, 4 traders, 3 students, and 2 farmers
Clinical Presentation of AIDS-KS
Kaposi sarcoma skin lesions were described mainly in the lower (n ¼ 19) and upper limbs (n ¼ 12). Three female patients had generalized skin lesions (defined as multiple lesions located on 3 or more anatomical sites. The commonest types of lesions were nodules (n ¼ 19) and papules (n ¼ 16). Ulcerated lesions and plaque-like lesions as well as ecchymotic and keloidal lesions were also described. Of the 20 patients, 12 (60%) had locally invasive skin lesions. No case of lymph node AIDS-KS was found in this series. The clinical photos of lesions are shown in Figures 1 to 5 .
The diseases associated with AIDS-KS at the time of presentation included HIV-related diarrhea (n ¼ 5), acute bacterial sepsis (n ¼ 2), disseminated tuberculosis (DTB) involving the lungs and lymph node (n ¼ 2), confirmed by lymph node histology and chest x-ray, and pulmonary tuberculosis (PTB, n ¼ 1) diagnosed by clinical history and chest x-ray findings. 
Laboratory Results
The median (and range) packed cell volume (PCV) and CD4 counts of patients were 28% (19-39) and 245 cells/mm 3 (55-840), respectively. Of the 20 patients, 8 (40%) were anemic (PCV < 30%) while 12 (80%) had PCV !30%. Using the World Health Organization (WHO) categorization of CD4 counts in HIV/AIDS disease, 14 Of the 20 patients, 17 (85%) were HHV8-seropositive, while 3 (15%) were HHV8-seronegative.
Gender differences in clinical and laboratory data of patients are shown in Table 1 . Compared to males, females were more likely to have generalized skin lesions, lower CD4 count, lower PCV, and higher rates of associated opportunistic infections.
TIS AIDS-KS Staging
Based on the TIS staging, 2 (10%) had good risk AIDS-KS, while 18 patients (90%) had poor risk AIDS-KS.
Discussion
In this study, a high positive HHV8-seroprevalence rate of 85% was found among the patients with AIDS-KS, in Zaria, Nigeria. This finding is supportive of an etiological role of HHV8 in our patients with AIDS-KS and compares with reports from Brazil, 15 and Cuba, 16 where rates of 79.5% and 77.8%, respectively, were found in patients with AIDS-KS. The reported rate is, however, lower than those reported in patients with AIDS-KS, from Tanzania, 17 Central Africa republic, 18 and Zambia, 19 where rates of 96.4%, 94%, and 92.3% were, respectively, found. In view of the confirmed etiologically link between HHV8 and AIDS-KS, a 100% HHV8-seroprevalence is expected but not always documented in patients with AIDS-KS. This is as a result of the varying sensitivity of serological detections methods rather than misdiagnosis. 20 The fact that all our patients with AIDS-KS were heterosexuals may suggest that HHV8 infection might have been acquired mainly by sexual transmission, although a nonsexual route of transmission may also be operative, as HHV8 infection have been reported in Nigerian children. 21 The findings of this study confirm the multicentric presentation of AIDS-KS, as lesions were located on the skin in virtually every part of the body and also involved the oropharynx. Although lesions affecting viscera were not obvious in our series, asymptomatic viscera KS have been diagnosed by invasive imaging techniques or after autopsy. 22 The diversities of skin lesions were also evident in our cases as even rare manifestations such as ecchymotic and keliodal lesions 3 were also described. Clinicians ought, therefore, to always consider or exclude KS in any HIV-infected patient with a skin lesion.
The lower limb was found to be the commonest site for KS lesions, which is similar to the findings of other studies from Nigeria. 8, 9, 23 The reasons for the predominant lower limb involvement remain speculative. First, the propensity of KS lesions to occur in areas of trauma 3 -Koebner phenomenonworks in favor of development of lesions in the lower limb, as it is the most commonly traumatized part of the body. Second, hypoxia is known to induce lytic replication of HHV8 and consequently promote KS development. 24 For this reason, Davis et al, 24 , had suggested that relative hypoxia in the lower limbs compared to other parts of the body promoted KS, developing more frequently in the lower limbs.
The study results show that AIDS-KS can occur with or without significant decline in CD4 count, which is similar to the findings of an earlier study from our region in Nigeria. 25 Although, a low CD4 count is an independent predictor of progression to KS, 26, 27 HIV-1 tat protein and cytokines (such as tumor necrosis factor-a [TNF-a], interleukin 6 [IL-6], IL-8, Oncostatin M), released during immune activation, may also promote progression to KS independent of CD4 counts by transactivating HHV8 and promoting lytic replication of HHV8. 28, 29 The possible roles of other risk factors such as host genetic, host human leucoctye antigen, and environmental factors, 30 in promoting progression to AIDS-KS in HIV-HHV8-co-infected Nigerians await future studies. Abbreviations: N, number of patients; PCV, packed cell volume, ART, antiretroviral therapy; KS, Kaposi sarcoma.
Using the ACTG 12 staging of KS, majority of our patients had poor risk KS, with most patients having locally invasive disease. These findings are in keeping with the predominant aggressive nature of KS in HIV-infected patients 3 and are similar to an earlier study of AIDS-KS from our center. 11 It is noteworthy that our female patients had higher rates of generalized KS, lower mean PCV, and lower CD4 counts than males. More females than males were antiretroviral therapy (ART) naive at presentation and did not benefit from the immune-restorative effects of ART as reflected in their lower CD4 counts. Alternatively, it may also be suggested that since the female immune response generally appear more robust than that of males, 31 females may be predisposed to develop an exaggerated response to HHV8 infection. Such immune hyperactivity may be associated by immune exhaustion and immunosuppression. 32 The former may lead to increased appearance of KS lesions, while the latter increases the risk of comorbid potentially fatal opportunistic infections in female patients. Similarly, several studies from Africa and other parts of the world have consistently reported a more severe presentation and a poorer prognosis in females than males even with similar clinical status with regard to HIV disease. [33] [34] [35] Delay in diagnosis in females due to low index of suspicion was implicated as a factor in 1 study 35 but hormonal factors may also be relevant. 36 . Female patient with multinodular KS lesions affecting the whole of the right lower limb with associated lymphedema, ulceration, and purulent discharge. KS indicates Kaposi sarcoma. infection and presents with a variety of skin manifestations that are often aggressive, advanced, and worse in females. Effective HAART, prevention and treatment of opportunistic infections, and use of KS-targeted therapy where indicated, remain the cornerstone for reducing the morbidity and mortality associated with AIDS-KS.
